Zurcher Kantonalbank (Zurich Cantonalbank) Voyager Therapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

  • $34.1 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 30, 2021
SELL
$3.94 - $5.44 $8,376 - $11,565
-2,126 Closed
0 $0
Q2 2019

Jul 30, 2019
BUY
$19.18 - $27.88 $32,126 - $46,699
1,675 Added 371.4%
2,126 $58,000
Q1 2019

Apr 29, 2019
SELL
$8.0 - $19.66 $7,792 - $19,148
-974 Reduced 68.35%
451 $9,000
Q2 2018

Aug 06, 2018
SELL
$16.76 - $23.92 $26,112 - $37,267
-1,558 Reduced 52.23%
1,425 $28,000
Q1 2018

May 03, 2018
BUY
$16.16 - $31.31 $48,205 - $93,397
2,983 New
2,983 $56,000

Others Institutions Holding VYGR

# of Institutions
135
Shares Held
34.4M
Call Options Held
6K
Put Options Held
60.4K
View Full List

About Voyager Therapeutics, Inc.

VYGR Quotes by TradingView
  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $150M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email